November 23, 2021
Article
The federal agency's decision makes this the first CMV treatment for this patient population.
November 03, 2021
In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.
October 31, 2021
Incidences of Clostridioides difficile infection have risen in recent years, and understanding risk factors can help practitioners address associated mortality, morbidity and health care costs.
October 24, 2021
Unapproved stem cell treatments derived from umbilical cord blood can pose potential risks to patients without proven benefits, a CDC study shows.
October 18, 2021
Lack of data may mean bloodstream infections caused by PVCs are an overlooked cause of morbidity in hospitalized patients.
October 14, 2021
October 12, 2021
Investigators found no significant difference among hospitalized patients in the ICU being administered probiotics vs placebo.
October 09, 2021
Video
Providers offer their insights on this important topic.
October 08, 2021
If the FDA approves maribavir, it will be the first and only treatment for adults with CMV as a result of a hematopoietic stem cell transplant or solid organ transplant.
A global study of C. difficile isolates worldwide found a very high prevalence of the bacteria on shoe soles.
